incision 发表于 2025-3-25 04:45:25

http://reply.papertrans.cn/29/2831/283063/283063_21.png

刺激 发表于 2025-3-25 08:20:32

http://reply.papertrans.cn/29/2831/283063/283063_22.png

带子 发表于 2025-3-25 15:00:27

Reverse Engineering Drugs: Lorcaserin as an Example,

Stress 发表于 2025-3-25 17:42:33

http://reply.papertrans.cn/29/2831/283063/283063_24.png

progestin 发表于 2025-3-25 21:14:55

Drug Development in Psychiatry: The Long and Winding Road from Chance Discovery to Rational Develophanism of action: blockade of the glutamate NMDA receptor. These studies coupled with earlier studies with other NMDA drugs suggest approximately 60% of patient with TRD are rapidly and robustly responsive to this mechanism of action. Thus, there appears to be three forms of MD based on pharmacologi

没有准备 发表于 2025-3-26 00:23:33

http://reply.papertrans.cn/29/2831/283063/283063_26.png

易受刺激 发表于 2025-3-26 07:41:57

http://reply.papertrans.cn/29/2831/283063/283063_27.png

无动于衷 发表于 2025-3-26 10:12:40

Discovery and Development of Monoamine Transporter Ligands, result in their behavioral effects. This review focusses on recent examples of ligand-based structure-activity relationship studies trying to overcome some of the challenges associated with previously developed MAT inhibitors. These studies have led to the discovery of unique and novel structurally

树木中 发表于 2025-3-26 14:36:47

http://reply.papertrans.cn/29/2831/283063/283063_29.png

PAC 发表于 2025-3-26 17:17:19

http://reply.papertrans.cn/29/2831/283063/283063_30.png
页: 1 2 [3] 4 5 6
查看完整版本: Titlebook: Drug Development in Psychiatry; Matthew Macaluso,Sheldon H. Preskorn,Richard C. Sh Book 2023 The Editor(s) (if applicable) and The Author(